June 30, 2025 · Form 4 insider transaction
Dahlquist Karl S. bought 822 shares of AtriCure, Inc. at $25.84 per share, a transaction worth $21.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2025.; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2025, which is the first trading day of the applicable offering period. The closing price on January 2, 2025 was $30.40.